18F-FDG PET/CT显像中活跃棕色脂肪界定具有特征性表现且棕色脂肪再检出概率增高的患者群体
该回顾性分析纳入1,644例患者的2,854次18F-FDG PET/CT扫描,其中81例患者的98次扫描显示活跃棕色脂肪(BAT)。高活性BAT平均总体积为308±208 mL;BAT阳性患者重复扫描再检出活跃BAT的平均概率为52%±25%,远高于总体患病率4.9%。年轻患者总BAT活性指数较高(P=0.009),估计肾肌酐清除率与BAT活性指数显著相关(P=0.005)。
要点
- 81例患者98次扫描检出活跃BAT,高活性者平均总体积308±208 mL。
- BAT阳性患者重复扫描再检出活跃BAT平均概率52%±25%,总体患病率4.9%。
- 年轻患者总BAT活性指数更高(P=0.009),估计肾肌酐清除率与BAT活性指数相关(P=0.005)。
核心结论
- BAT阳性患者在扫描中激活BAT的概率高于一般水平。
- 估计肾肌酐清除率与给定扫描中激活BAT的范围相关。
- 这些数据提示靶向BAT治疗代谢疾病的药物疗效可能比先前假设的更高,同时个体变异也更大。
研究设计与样本
- 回顾性分析1,644例患者的2,854次18F-FDG PET/CT扫描,识别出81例患者的98次扫描显示活跃BAT。
- 采用视觉评分策略将32次最高活性扫描归类,计算平均总BAT体积。
- 在30例有3次及以上重复扫描的BAT阳性患者中计算再检出活跃BAT的平均概率。
主要发现
- 活跃BAT体积均值±SD:总体162±183 mL(n=98)、颈部40±37 mL(n=53)、锁骨上66±68 mL(n=71)、椎旁51±53 mL(n=69)、纵隔43±40 mL(n=51)、膈下21±21 mL(n=29)。
- 仅取32次最高活性扫描时,平均总BAT体积为308±208 mL。
- 30例BAT阳性患者重复扫描再检出活跃BAT的平均概率为52%±25%,总体患病率为4.9%。
- 年轻患者总BAT活性指数更高(P=0.009);性别、体质指数、身高、体重、室外温度和血液参数未影响总或各部位BAT活性。
- 估计肾肌酐清除率是总BAT活性指数(P=0.005)及多个单独部位BAT活性指数的显著预测因子。
关键数值与推荐
- 活跃BAT体积均值±SD:总体162±183 mL(n=98)、颈部40±37 mL(n=53)、锁骨上66±68 mL(n=71)、椎旁51±53 mL(n=69)、纵隔43±40 mL(n=51)、膈下21±21 mL(n=29)。
- 最高活性32次扫描的平均总BAT体积为308±208 mL。
- 30例BAT阳性患者重复扫描再检出活跃BAT的平均概率为52%±25%,总体患病率为4.9%。
- 年轻患者总BAT活性指数更高(P=0.009)。
- 估计肾肌酐清除率与总BAT活性指数相关(P=0.005)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Brown adipose tissue (BAT) provides a means of nonshivering thermogenesis. In humans, active BAT can be visualized by 18F-FDG uptake as detected by PET combined with CT. The retrospective analysis of clinical scans is a valuable source to identify anthropometric parameters that influence BAT mass and activity and thus the potential efficacy of envisioned drugs targeting this tissue to treat metabolic disease. Methods: We analyzed 2,854 18F-FDG PET/CT scans from 1,644 patients and identified 98 scans from 81 patients with active BAT. We quantified the volume of active BAT depots (mean values in mL ± SD: total BAT, 162 ± 183 [n = 98]; cervical, 40 ± 37 [n = 53]; supraclavicular, 66 ± 68 [n = 71]; paravertebral, 51 ± 53 [n = 69]; mediastinal, 43 ± 40 [n = 51]; subphrenic, 21 ± 21 [n = 29]). Because only active BAT is detectable by 18F-FDG uptake, these numbers underestimate the total amount of BAT. Considering only 32 scans of the highest activity as categorized by a visual scoring strategy, we determined a mean total BAT volume of 308 ± 208 mL. In 30 BAT-positive patients with 3 or more repeated scans, we calculated a much higher mean probability to redetect active BAT (52% ± 25%) as compared with the overall prevalence of 4.9%. We calculated a BAT activity index (BFI) based on volume and intensity of individual BAT depots. Results: We detected higher total BFI in younger patients (P = 0.009), whereas sex, body mass index, height, mass, outdoor temperature, and blood parameters did not affect total or depot-specific BAT activity. Surprisingly, renal creatinine clearance as estimated from mass, age, and plasma creatinine was a significant predictor of BFI on the total (P = 0.005) as well as on the level of several individual depots. In summary, we detected a high amount of more than 300 mL of BAT tissue. Conclusion: BAT-positive patients represent a group with a higher than usual probability to activate BAT during a scan. Estimated renal creatinine clearance correlated with the extent of activated BAT in a given scan. These data imply an efficacy of drugs targeting BAT to treat metabolic disease that is at the same time higher and subject to a larger individual variation than previously assumed.
引用
- Gerngroß C, Schretter J, Klingenspor M, et al. Active Brown Fat During 18F-FDG PET/CT Imaging Defines a Patient Group with Characteristic Traits and an Increased Probability of Brown Fat Redetection. J Nucl Med. 2017. PMID: 28104743. doi:10.2967/jnumed.116.183988
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。